帕姆德尔芬通过下调环指蛋白145抑制卵巢癌细胞干细胞的特异化
Nanzi Xie1, Sisi Mei1, Changlan Dai1
1Department of Pathology, People's Hospital of Anshun City Guizhou Province, Anshun 561000, Guizhou, China.
Critical reviews in eukaryotic gene expression
|August 24, 2024
概括
该研究发现,PALMD在卵巢癌中是下调的. 恢复PALMD的表达抑制了卵巢癌细胞的增殖,迁移,入侵和干细胞通过降低RNF145.5的调节.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 卵巢癌是一个重要的健康问题,具有复杂的潜在机制.
- 卵巢癌干细胞 (CSCs) 在瘤进展和治疗耐药性方面发挥着至关重要的作用.
研究的目的:
- 为了研究PALMD (palmdelphin) 在卵巢癌中的作用.
- 阐明 PALMD 影响卵巢癌进展和干性的分子机制.
主要方法:
- 定量实时PCR (RT-qPCR) 用于mRNA表达分析.
- 流细胞计测量以评估阿尔代脱酶 (ALDH) 活性和CSC生物标志物.
- 球体形成,CCK-8和殖民地形成测试用于细胞干细胞和活力.
- 伤口愈合和Transwell测试以评估细胞迁移和入侵.
主要成果:
- 在卵巢癌组织中,PALMD的表达显著下调.
- 过度表达PALMD抑制了卵巢癌细胞的增殖,迁移和入侵.
- PALMD抑制了卵巢癌细胞的干状特性,包括ALDH活性和球体形成.
- PALMD降低了环指蛋白145 (RNF145) 的表达,这种蛋白与卵巢癌的攻击性有关.
结论:
- PALMD在卵巢癌中起到瘤抑制作用.
- PALMD抑制卵巢癌细胞干细胞和攻击性,至少部分是通过抑制RNF145表达.
相关概念视频
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


